Tag Archives: U.S. House Committee on Oversight and Government Reform

Mylan Agrees to $465 Million EpiPen Settlement with US; But the Matter is Far From Over

Mylan NV (Amsterdam) will pay the US government $465 million in a swift settlement over how the drugmaker charged Medicaid for its allergy shot EpiPen, according to Bloomberg News. The… Read more »

Mylan CEO Bent Truth About Epipen Profit; Sadly Follows Path of Valeant, Turing Pharma

Controversial Mylan NV (Amsterdam) CEO Heather Bresch was grilled in a marathon committee hearing about the EpiPen’s pricing before Congress last week. But it turns out that several of her… Read more »

Lawmakers Unimpressed with Mylan CEO’s Defense of EpiPen Pricing; Fact that She’s a Senator’s Daughter Not Beneficial

Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan NV (Amsterdam) about the significant cost increase of its life-saving EpiPens and the profits for a company with… Read more »

Mylan Reportedly Paid Its Top Execs More than Industry Giants

Mylan, the Amsterdam-based company facing copious scrutiny from the media, consumers and politicians for its drug pricing practices, ranks second-highest among all U.S. drug and biotech firms in executive compensation,… Read more »

Mylan Plans Generic EpiPen to Calm Pricing Outrage; Feels More Like a PR Move

Mylan NV’s latest attempt to deflect criticism over the price of allergy shot EpiPen failed to get the drugmaker out of the crosshairs of Congress this week. Last week, Chief… Read more »